Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Immuron Says It Deprioritized SARS-COV-2 Research

Aug 19 (Reuters) - Immuron Ltd  IMC.AX :
    * IMMURON UPDATE ON IMM-124E SARS-COV-2 RESEARCH-IMC.AX
    * HAS DEPRIORITIZED SARS-COV-2 RESEARCH TO FOCUS ON CLINICAL
DEVELOPMENT OF ADVANCED STAGE THERAPEUTIC DRUG CANDIDATES

Source text for Eikon:  ID:nASX7hmS34 
Further company coverage:  IMC.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Immuron

See all news